Target intelligence / Profile preview

Growth arrest-specific transcript 5 (GAS5)

Target
GAS5
Molecular classification
Long non-coding RNA (lncRNA), Non-protein-coding RNA, Member of the 5ʹ-terminal oligopyrimidine gene family, Regulatory RNA
01

Overview

Growth arrest-specific transcript 5 (GAS5) is a long non-coding RNA encoded at chromosome 1q25.1, and comprises 12 exons. It does not code for a protein, but rather regulates gene expression by acting as a molecular sponge for miRNAs, serving as a scaffold/guide for transcription factors, and influencing multiple cell signaling pathways including mTOR, p53, AKT, and glucocorticoid receptor signaling. GAS5 is a known tumor suppressor, with decreased expression observed in many cancers and neurodegenerative diseases. In neurons and metabolic tissues, GAS5 modulates insulin signaling and neuroinflammation, and its levels are reduced in conditions such as type 2 diabetes and Alzheimer's disease. GAS5 is being explored as both a biomarker and a therapeutic target, with small-molecule modulators like NPC86 showing preclinical promise for disease intervention. Regulation of cell proliferation, apoptosis, stem cell self-renewal, and neuronal survival are among its key biological processes.

Other names
GAS5 lncRNAGrowth arrest-specific 5 lncRNAlncRNA GAS5GAS5 RNA
02

Mechanism of action

Small molecules such as NPC86 bind GAS5, increase its expression, enhance insulin receptor levels, and modulate neuroinflammation

03

Biological functions

Regulation of cell cyclePromotion of cell apoptosisInhibition of cell proliferationTumor suppressionRegulation of insulin signalingNeuronal survival and neuroinflammationControl of stem cell self-renewal and pluripotencyModulation of mTOR, p53, AKT, glucocorticoid receptor signaling pathwaysSponge for microRNAs (miRNA)Guide/decoy for transcription factorsRegulation of mitochondrial function and synapse function
04

Disease associations

Cancer (solid tumors: gastric, lung, hepatic, renal, breast, etc.)Neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson's disease)Type 2 diabetes and metabolic diseaseInflammationAging
05

Safety considerations

Off-target effects of lncRNA-targeting drugs remain a consideration, though NPC86 appears highly specific for GAS5 based on current researchLimited clinical studies; most data are preclinicalModulation of GAS5 may affect multiple pathways due to its pleiotropic regulatory roles
06

Interacting drugs

NPC86
07

Biomarkers

GAS5 expression level (potential diagnostic/prognostic biomarker in cancers, diabetes, and neurodegeneration)Downregulated GAS5 associated with poor prognosis in cancer and aging brainsGAS5 levels may correlate with insulin receptor expression and metabolic health

Beyond the preview

Go deeper on Growth arrest-specific transcript 5 (GAS5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Growth arrest-specific transcript 5 (GAS5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call